Carcinoma cell-specific Mig-7: A new potential marker for circulating and migrating cancer cells

Oncology Reports

Volumn 13, Issue 1, 2005, Pages 37-44

  Phillips, Troy M ^a   Lindsey, J Suzanne ^a,b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Biomarker; Carcinoma specific; Integrin; Occult tumor cells; Receptor tyrosine kinase

Indexed keywords

MESSENGER RNA; MIG 7 PROTEIN, HUMAN; MIG-7 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL; ARTICLE; CANCER INVASION; CELL CULTURE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; FEMALE; GENETICS; HUMAN; METABOLISM; MOUSE; PATHOLOGY; TUMOR EMBOLISM;

ANIMALS; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MICE; NEOPLASM CIRCULATING CELLS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 21644468581     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.1.37     Document Type: Article

References (31)

1. Ghossein RA, Bhattacharya S and Rosai J: Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res 5: 1950-1960, 1999. (Pubitemid 29399243)
2. Raynor M, Stephenson SA, Walsh DC, Pittman KB and Dobrovic A: Optimisation of the RT-PCR detection of immunornagnetically enriched carcinoma cells. BMC Cancer 2: 14, 2002.
3. Vlems FA, Diepstra JHS, Cornelissen IMHA, Ruers TJM, Ligtenberg MJL, Punt CJA, van Krieken JHJM, Wobbes T and van Muijen GNP: Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and down-regulation in tumor tissue. J Clin Pathol 55: 156-163, 2002. (Pubitemid 34620765)
4. Hellström I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, Mcintosh M, Drescher C, Urban N and Hellström KE: The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res 63: 3695-3700, 2003.
5. Valdes F, Alvarez AM, Locascio A, Vega S, Herrera B, Fernandez M, Benito M, Nieto MA and Fabregat I: The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor (β) in fetal rat hepatocytes. Mol Cancer Res 1: 68-78, 2002. (Pubitemid 36330212)
6. Webb T: Microarray studies challenge theories of metastasis. J Natl Cancer Inst 95: 350-351, 2003.
7. Crouch S, Spidel CS and Lindsey JS: HGF and ligation of αvβ5 integrin induce a novel, cancer cell-specific gene expression required for cell scattering. Exp Cell Res 292: 274-287, 2004. (Pubitemid 38018843)
8. Brooks PC, Klemke RL, Schon S, Lewis JM, Schwartz MA and Cheresh DA: Insulin-like growth factor receptor cooperates with integrin αvβ5 to promote tumor cell dissemination in vivo. J Clin Invest 99: 1390-1398, 1997. (Pubitemid 27142777)
9. Klemke RL, Yebra M, Bayna EM and Cheresh DA: Receptor tyrosine kinase signaling required for integrin αvβ5-directed cell motility but not adhesion on vitronectin. J Cell Biol 127: 859-866, 1994. (Pubitemid 24332979)
10. Vande Woude GF, Jeffers M, Conner J, Alvord G, Tsarfaty I and Resau J: Met-HGF/SF: tumorigenesis, invasion and metastasis. Ciba Found Symp 212: 119-130, 1997.
11. Chenchik A, Zhu Y, Diatchenko L, Li R, Hill J and Siebert PD: Generation and use of high-quality cDNA from small amounts of total RNA by SMART PCR.MA: Biotechniques Books, 1998.
12. Wagatsuma S, Konno R, Sato S and Yajima A: Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. Cancer 82: 520-530, 1998. (Pubitemid 28112991)
13. Comoglio PM and Trusolino L: Invasive growth: from development to metastasis. J Clin Invest 109: 857-862, 2002. (Pubitemid 34275105)
14. Shariat SF, Roudier MP, Wilcox GE, Kattan, MW, Scardino P, Vessella RL, Erdamar S, Nguyen C, Wheeler TM and Slawin KM: Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes. Cancer Res 63: 4662-4670, 2003. (Pubitemid 36951045)
15. Gull B, Karlsson B, Milsom I and Garnberg S: Can ultrasound replace dilation and currettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer. Am J Obstet Gynecol 188: 401-408, 2003. (Pubitemid 36253637)
16. Obermair A, Hanzal E, Schreiner-Frech I, Buxbaum P, Bancher-Todesca D, Thoma M, Kurz C, Vavra N, Gitsch G and Sevelda P: Influence of delayed diagnosis on established prognostic factors in endometrial cancer. Anticancer Res 16: 947-949, 1996. (Pubitemid 26182037)
17. Brown GJ, St John DJ, Macrae FA and Aittomaki K: Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance. Gynecol Oncol 80: 346-349, 2001. (Pubitemid 32207533)
18. IchikawaY, Takano K, Higa S, Tanabe M, Wada A, Sugita M, Tsunoda H and Nishida M: Endometrial carcinoma coexisting with pregnancy, presumed to derive from adenomyosis: a case report. Int J Gynecol Cancer 11: 488-490, 2001. (Pubitemid 34024809)
19. Sasaki T, Sugiyama T, Nanjo H, Hoshi N, Murakami M, Sugita A, Takahashi M, Kawamura K, Ono I and Masuda H: Endometrioid adenocarcinoma arising from adenomyosis: report and immunohistochemical analysis of an unusual case. Pathol Int 51: 308-313, 2001. (Pubitemid 32472705)
20. Koshiyama M, Morita Y, Fujii H, Kobashi Y and Yoshida M: Gynecologic malignancies accompanied by benign hormone-dependent diseases. Menopause 8: 149-150, 2001. (Pubitemid 32199681)
21. Blot E, Decaudin D, Veyradier S, Bardier A, Zagame OL and Pouillart P: Cancer-related thrombotic microangiopathy secondary to von Willebrand factor-cleaving protease deficiency. Thromb Res 106: 127-130, 2002. (Pubitemid 35245236)
22. 34+progenitor cells in peripheral blood. J Clin Oncol 19: 3951-3959, 2001.
23. Southall PJ, Boxer GM, Bagshawe KD, Hole N, Bromley M and Stern PL: Immunohistological distribution of 5T4 antigen in normal and malignant tissues. Br J Cancer 61: 89-95, 1990.
24. Kopreski MS, Benko FA and Gocke CD: Circulating RNA as a tumor marker: detection of 5T4 mRNA in breat and lung cancer patient serum. An NY Acad Sci 945: 172-178, 2001. (Pubitemid 33022450)
25. Ali A, Langdon J, Stern P and Partridge M: The pattern of expression of the 5T4 oncofoetal antigen on normal, dysplastic and malignant oral mucosa. Oral Oncol 37: 57-64, 2001.
26. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M and Damsky CH: Human cytotrophoblasts adopt a vascular phenotype as they differentiate. J Clin Invest 99: 2139-2151, 1997.
27. Ribatti D, Vacca A and Dammacco F: New non-angiogenesis dependent pathways for tumour growth. Eur J Cancer 39: 1835-1841, 2003. (Pubitemid 37311178)
28. Sood AK, Fletcher MS and Hendrix MJ: The embryonic-like properties of aggressive human tumor cells. J Soc Gynecol Investig 9: 2-9, 2002. (Pubitemid 34143100)
29. Morello S, Olivero M, Aimetti M, Bernardi M, Di Renzo MF, Berrone S and Giordano S: Met receptor is overexpressed but not mutated in oral squamous cell carcinomas. J Cell Physiol 189: 285-290, 2001. (Pubitemid 33063296)
30. To CT and Tsao MS: The roles of hepatocyte growth factor/ scatter factor and met receptor in human cancers. Oncol Rep 5: 1013-1024, 1998. (Pubitemid 28372555)
31. Lessey BA, Ilesanmi AO, Lessey MA, Riben M, Harris JE and Chwalisz K: Luminal and glandular endometrial epithelium express integrins differentially throughout the menstrual cycle: implications for implantation, contraception, and infertility. Am J Reprod Immunol 35: 195-204, 1996. (Pubitemid 26082204)